In an article published from the Oncology Report Digital Network by Elizabeth Mechcatie, titled “FDA Grants Full Approval to Crizotinib for NSCLC Indication”, the Food and Drug Administration announced that a new drug was approved for the treatment of small cell lung cancer. Crizotinib is a kinase inhibitor that works by blocking the
Drug Studies
Reuters: Curis Places Testing of New Cancer Drug On Hold
By Staff on
Posted in Drug Studies
Last Wednesday (11/6/2013), Reuters reported that the approval of a new cancer drug by Curis Inc. has stalled after a patient died while taking the drug.
Curis Inc. is a company that develops many new drugs used for in cancer treatment. In collaboration with other major drug companies, Curis created Erivedge, the only medication for…
New Cancer Drug Ramucirumab (Eli Lilly & Co.) Prioritized by FDA
By Staff on
Posted in Drug Studies
Headquartered in Indianapolis, Indiana, Eli Lilly and Company is a pharmaceutical company with offices all over the world. Recently, the company developed a single-agent treatment for gastric cancer; a drug called Ramucirumab. Ramucirumab is used if cancer continues to progress after initial chemotherapy. And according to a report published 10-24-2013 by PharmaceuticalBusinessReview.com, the company recently…
FDA won’t say which drugs on the market were approved based on fraudulent research
By Justinian Lane on
Posted in Drug Studies, FDA Regulation
This shows that the FDA is more interested in protecting pharmaceutical companies than patients. Note how Woodcock doesn’t want to force new trials because that requires human experimentation, which has risk. A smarter regulator would realize that the risks increase in proportion to the size of the user base of the drug. And allowing any…
Secret payments to doctors put patient lives at risk
By Justinian Lane on
Posted in Drug Studies, Politics
A big part of what I do for a living is investigate the safety of drugs and medical devices. That means I spend time reading studies about the safety of a specific drug. One of the things I look at is the author of the study. If the author of the study discloses that he…
Dr. Steve Nissen Pushes For More Scrutiny Of Diabetes Drugs
By Justinian Lane on
Posted in Drug Studies, Misc. Drugs
Living legend Dr. Steve Nissen wants the FDA to pay more attention to the cardiovascular risks of diabetes drugs in the future:
ORLANDO — Should new diabetes drugs submitted to the FDA have a higher bar for cardiovascular safety than other drugs was the focus of a debate here between Steve E. Nissen, MD, and
…
New study shows risk of weight gain for users of antipsychotic drugs
By Justinian Lane on
Posted in Drug Studies
More evidence that certain drugs can cause diabetes…
Young children and adolescents who take the newest generation of antipsychotic medications risk rapid weight gain and metabolic changes that could lead to diabetes, hypertension and other illnesses, according to the biggest study yet of first-time users of the drugs.
The study, to be published
…